Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


Articles published in Int J Gynecol Cancer

Retrieve available abstracts of 151 articles:
HTML format
Text format



Single Articles


    July 2018
  1. LEE J, Chang CL, Lin JB, Wu MH, et al
    The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated Radiotherapy.
    Int J Gynecol Cancer. 2018 Jul 10. doi: 10.1097/IGC.0000000000001312.
    PubMed     Text format     Abstract available


    June 2018
  2. DOSTALEK L, Avall-Lundqvist E, Creutzberg CL, Kurdiani D, et al
    ESGO Survey on Current Practice in the Management of Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jun 28. doi: 10.1097/IGC.0000000000001314.
    PubMed     Text format     Abstract available


    May 2018
  3. NASSALI MN, Tadele M, Nkuba RM, Modimowame J, et al
    Predictors of Locally Advanced Disease at Presentation and Clinical Outcomes Among Cervical Cancer Patients Admitted at a Tertiary Hospital in Botswana.
    Int J Gynecol Cancer. 2018 May 23. doi: 10.1097/IGC.0000000000001284.
    PubMed     Text format     Abstract available


  4. KRANAWETTER M, Rohrich S, Mullauer L, Obermair H, et al
    Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data.
    Int J Gynecol Cancer. 2018 May 22. doi: 10.1097/IGC.0000000000001291.
    PubMed     Text format     Abstract available


  5. KOCAER M, Gulseren V, Ozdemir IA, Gungorduk O, et al
    Management of Vertebral Metastasis in Patients With Uterine Cervical Cancer.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001273.
    PubMed     Text format     Abstract available


  6. JALLOUL RJ, Sharma S, Tung CS, O'Donnell B, et al
    Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001264.
    PubMed     Text format     Abstract available


  7. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2018;28:641-655.
    PubMed     Text format     Abstract available


    April 2018
  8. TOMITA N, Mizuno M, Kondo S, Mori M, et al
    Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001279.
    PubMed     Text format     Abstract available


  9. CORRADO G, Vizza E, Legge F, Pedone Anchora L, et al
    Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001254.
    PubMed     Text format     Abstract available


  10. LI P, Zhang R, Nie Z, Long M, et al
    Comparison of Nedaplatin- and Cisplatin-Based Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer Patients: A Propensity Score Analysis.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001265.
    PubMed     Text format     Abstract available


  11. WELK B, Wallis C, D'Souza D, McGee J, et al
    A Population-Based Assessment of Urologic Procedures and Operations After Surgery or Pelvic Radiation for Cervical Cancer.
    Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001266.
    PubMed     Text format     Abstract available


    March 2018
  12. DERKS M, van der Velden J, de Kroon CD, Nijman HW, et al
    Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period.
    Int J Gynecol Cancer. 2018 Mar 27. doi: 10.1097/IGC.0000000000001228.
    PubMed     Text format     Abstract available


  13. RYCKMAN JM, Lin C, Simone CB 2nd, Verma V, et al
    Patterns of Care for Stage IA Cervical Cancer: Use of Definitive Radiation Therapy Versus Hysterectomy.
    Int J Gynecol Cancer. 2018 Mar 20. doi: 10.1097/IGC.0000000000001225.
    PubMed     Text format     Abstract available


  14. BASU P, Mehta A, Jain M, Gupta S, et al
    A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001235.
    PubMed     Text format     Abstract available


  15. LAIOS A, Kasius J, Tranoulis A, Gryparis A, et al
    Obstetric Outcomes in Women With Early Bulky Cervical Cancer Downstaged by Neoadjuvant Chemotherapy to Allow for Fertility-Sparing Surgery: A Meta-analysis and Metaregression.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001232.
    PubMed     Text format     Abstract available


  16. MINIG L, Fagotti A, Scambia G, Salvo G, et al
    Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular Invasion.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001236.
    PubMed     Text format     Abstract available


  17. PLOTTI F, Terranova C, Capriglione S, Crispino S, et al
    Assessment of Quality of Life and Urinary and Sexual Function After Radical Hysterectomy in Long-Term Cervical Cancer Survivors.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001239.
    PubMed     Text format     Abstract available


  18. NAIR VB, Manasa VG, Sinto MS, Jayasree K, et al
    Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Int J Gynecol Cancer. 2018;28:553-562.
    PubMed     Text format     Abstract available


    February 2018
  19. YOSHIHARA K, Ishiguro T, Chihara M, Shima E, et al
    The Safety and Effectiveness of Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy.
    Int J Gynecol Cancer. 2018 Feb 28. doi: 10.1097/IGC.0000000000001218.
    PubMed     Text format     Abstract available


    January 2018
  20. CIMA S, Perrone AM, Castellucci P, Macchia G, et al
    Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 24. doi: 10.1097/IGC.0000000000001207.
    PubMed     Text format     Abstract available


  21. O'DONNELL B, Shiao JC, Pezzi TA, Waheed N, et al
    Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    Int J Gynecol Cancer. 2018 Jan 10. doi: 10.1097/IGC.0000000000001200.
    PubMed     Text format     Abstract available


  22. CHONG GO, Lee YH, Lee HJ, Hong DG, et al
    Comparison of the Long-Term Oncological Outcomes Between the Initial Learning Period of Robotic and the Experienced Period of Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2018 Jan 4. doi: 10.1097/IGC.0000000000001172.
    PubMed     Text format     Abstract available


  23. KOJIMA A, Shimada M, Mikami Y, Nagao S, et al
    Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
    Int J Gynecol Cancer. 2018;28:99-106.
    PubMed     Text format     Abstract available


  24. HOU WH, Schultheiss TE, Wong JY, Wakabayashi MT, et al
    Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Int J Gynecol Cancer. 2018;28:188-193.
    PubMed     Text format     Abstract available


    November 2017
  25. KIM H, Kim YS, Joo JH, Eom KY, et al
    Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419).
    Int J Gynecol Cancer. 2017 Nov 17. doi: 10.1097/IGC.0000000000001155.
    PubMed     Text format     Abstract available


    October 2017
  26. KIYOTOKI T, Nakamura K, Haraga J, Omichi C, et al
    Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    Int J Gynecol Cancer. 2017 Oct 17. doi: 10.1097/IGC.0000000000001127.
    PubMed     Text format     Abstract available


  27. WEI WF, Han LF, Liu D, Wu LF, et al
    Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis.
    Int J Gynecol Cancer. 2017;27:1587-1595.
    PubMed     Text format     Abstract available


  28. HILLESHEIM I, Limone GA, Klimann L, Monego H, et al
    Cervical Cancer Posttreatment Follow-up: Critical Analysis.
    Int J Gynecol Cancer. 2017;27:1747-1752.
    PubMed     Text format     Abstract available


  29. LI X, Wang L, Li Y, Song P, et al
    The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery.
    Int J Gynecol Cancer. 2017;27:1761-1768.
    PubMed     Text format     Abstract available


    September 2017
  30. AL-HARBI NM, Bin Judia SS, Mishra KN, Shoukri MM, et al
    Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
    Int J Gynecol Cancer. 2017 Sep 13. doi: 10.1097/IGC.0000000000001103.
    PubMed     Text format     Abstract available


  31. TAKIUCHI T, Machida H, Hom MS, Mostofizadeh S, et al
    Association of Metformin Use and Survival Outcome in Women With Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1455-1463.
    PubMed     Text format     Abstract available


  32. CHENG J, Hou Y, Li J, Wang W, et al
    Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment: A Prospective Study.
    Int J Gynecol Cancer. 2017;27:1472-1479.
    PubMed     Text format     Abstract available


  33. LUO L, Zhang H, Nian S, Lv C, et al
    Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
    Int J Gynecol Cancer. 2017;27:1422-1430.
    PubMed     Text format     Abstract available


  34. LUAN T, Hua Q, Liu X, Xu P, et al
    PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
    Int J Gynecol Cancer. 2017;27:1480-1488.
    PubMed     Text format     Abstract available


    August 2017
  35. NIE JC, Yan AQ, Liu XS
    Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the Treatment of Cervical Cancer.
    Int J Gynecol Cancer. 2017 Aug 31. doi: 10.1097/IGC.0000000000001101.
    PubMed     Text format     Abstract available


    July 2017
  36. LUCIDI A, Windemut S, Petrillo M, Dessole M, et al
    Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001045.
    PubMed     Text format     Abstract available


  37. CHANTALAT E, Vidal F, Motton S
    Letter to the Editor on "Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer": What is the Best Approach? Int J Gynecol Cancer. 2017 Mar; 27(3): 543549.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001085.
    PubMed     Text format    


  38. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Factors Contributing to the Low Survival Among Women With a Diagnosis of Invasive Cervical Cancer in Ghana.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001088.
    PubMed     Text format     Abstract available


  39. PANG T, Li M, Zhang Y, Yong W, et al
    Y Box-Binding Protein 1 Promotes Epithelial-Mesenchymal Transition, Invasion, and Metastasis of Cervical Cancer via Enhancing the Expressions of Snail.
    Int J Gynecol Cancer. 2017 Jul 13. doi: 10.1097/IGC.0000000000001066.
    PubMed     Text format     Abstract available


  40. VAN GENT MDJM, Rademaker M, van der Veer JCB, van Poelgeest MIE, et al
    Long-Term Oncological Outcome After Conventional Radical Hysterectomy Versus 2 Nerve-Sparing Modalities for Early Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001067.
    PubMed     Text format     Abstract available


  41. MACHIDA H, Eckhardt SE, Antonio C, Blake EA, et al
    Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States.
    Int J Gynecol Cancer. 2017 Jul 12. doi: 10.1097/IGC.0000000000001068.
    PubMed     Text format     Abstract available


  42. ZHU T, Chen X, Zhu J, Chen Y, et al
    Surgical and Pathological Outcomes of Laparoscopic Versus Abdominal Radical Hysterectomy With Pelvic Lymphadenectomy and/or Para-aortic Lymph Node Sampling for Bulky Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:1222-1227.
    PubMed     Text format     Abstract available


  43. JUNG EJ, Byun JM, Kim YN, Lee KB, et al
    Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1228-1236.
    PubMed     Text format     Abstract available


  44. HONG MK, Wang JH, Su CC, Li MH, et al
    Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1247-1255.
    PubMed     Text format     Abstract available


    June 2017
  45. SONG MK, Shin BS, Ha CS, Park WY, et al
    Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?
    Int J Gynecol Cancer. 2017 Jun 23. doi: 10.1097/IGC.0000000000001046.
    PubMed     Text format     Abstract available


  46. CANAZ E, Ozyurek ES, Erdem B, Aldikactioglu Talmac M, et al
    Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 14. doi: 10.1097/IGC.0000000000001060.
    PubMed     Text format     Abstract available


  47. POKA R, Molnar S, Darago P, Lukacs J, et al
    Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical Cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001048.
    PubMed     Text format     Abstract available


  48. GULER OC, Sari SY, Birgi SD, Gultekin M, et al
    Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001029.
    PubMed     Text format     Abstract available


  49. ECHEVERRIA A, Manley H, O'Donnell B, Asper J, et al
    Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System.
    Int J Gynecol Cancer. 2017 Jun 10. doi: 10.1097/IGC.0000000000001035.
    PubMed     Text format     Abstract available


  50. SALIHI R, Leunen K, Moerman P, Amant F, et al
    Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Int J Gynecol Cancer. 2017 Jun 1. doi: 10.1097/IGC.0000000000001021.
    PubMed     Text format     Abstract available


  51. YANG L, Zheng A, Zhang X, Fang X, et al
    Clear Cell Carcinoma of the Uterine Cervix: A Clinical and Pathological Analysis of 47 Patients Without Intrauterine Diethylstilbestrol Exposure.
    Int J Gynecol Cancer. 2017;27:1009-1014.
    PubMed     Text format     Abstract available


  52. LIU CZ, Zeng HX, Zhao JJ, Rong Y, et al
    The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2017;27:994-1000.
    PubMed     Text format     Abstract available


    May 2017
  53. DERKS M, Groenman FA, van Lonkhuijzen LRCW, Schut PC, et al
    Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000974.
    PubMed     Text format     Abstract available


  54. BAKKER RM, Pieterse QD, van Lonkhuijzen LRCW, Trimbos BJBMZ, et al
    A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000986.
    PubMed     Text format     Abstract available


  55. PLANTE M, Renaud MC, Sebastianelli A, Gregoire J, et al
    Simple Vaginal Trachelectomy: A Valuable Fertility-Preserving Option in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000989.
    PubMed     Text format     Abstract available


  56. ZHENG RR, Huang XW, Liu WY, Lin RR, et al
    Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000987.
    PubMed     Text format     Abstract available


  57. TOMAO F, Maruccio M, Preti EP, Boveri S, et al
    Conization in Early Stage Cervical Cancer: Pattern of Recurrence in a 10-Year Single-Institution Experience.
    Int J Gynecol Cancer. 2017 May 8. doi: 10.1097/IGC.0000000000000991.
    PubMed     Text format     Abstract available


  58. WEN Q, Liu Y, Lyu H, Xu X, et al
    Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 May 2. doi: 10.1097/IGC.0000000000001028.
    PubMed     Text format     Abstract available


  59. DEVOR EJ, Reyes HD, Gonzalez-Bosquet J, Warrier A, et al
    Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.
    Int J Gynecol Cancer. 2017;27:784-790.
    PubMed     Text format     Abstract available


    April 2017
  60. ROSEN VM, Guerra I, McCormack M, Nogueira-Rodrigues A, et al
    Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Int J Gynecol Cancer. 2017 Apr 26. doi: 10.1097/IGC.0000000000001000.
    PubMed     Text format     Abstract available


    March 2017
  61. ZHANG Y, Gao H, Gao X, Huang S, et al
    Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.
    Int J Gynecol Cancer. 2017 Mar 24. doi: 10.1097/IGC.0000000000000928.
    PubMed     Text format     Abstract available


  62. LEE JW, Jeon S, Mun ST, Lee SM, et al
    Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000949.
    PubMed     Text format     Abstract available


  63. WANG Q, Wei Y, Zhang J
    Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000951.
    PubMed     Text format     Abstract available


  64. LIU ZS, Guo J, Zhao YZ, Lin X, et al
    Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Int J Gynecol Cancer. 2017 Mar 6. doi: 10.1097/IGC.0000000000000929.
    PubMed     Text format     Abstract available


  65. GUNTUPALLI SR, Sheeder J, Ioffe Y, Tergas A, et al
    Sexual and Marital Dysfunction in Women With Gynecologic Cancer.
    Int J Gynecol Cancer. 2017;27:603-607.
    PubMed     Text format     Abstract available


    February 2017
  66. GUBBI A, Kacheria S, Ahmad S, Stavitzski NM, et al
    Prognostic Significance of the Standardized Uptake Value of Pretherapeutic 18F-Labeled 2-Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000930.
    PubMed     Text format     Abstract available


  67. MABUCHI S, Kimura T
    Extraperitoneal Radical Trachelectomy With Pelvic Lymphadenectomy: A Novel Fertility-Preserving Option for Early Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000918.
    PubMed     Text format     Abstract available


  68. KOENSGEN D, Sehouli J, Belau A, Weiss M, et al
    Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
    Int J Gynecol Cancer. 2017 Feb 10. doi: 10.1097/IGC.0000000000000894.
    PubMed     Text format     Abstract available


  69. PETITNICOLAS C, Azais H, Ghesquiere L, Tresch-Bruneel E, et al
    Morbidity of Staging Inframesenteric Paraaortic Lymphadenectomy in Locally Advanced Cervical Cancer Compared With Infrarenal Lymphadenectomy.
    Int J Gynecol Cancer. 2017 Feb 4. doi: 10.1097/IGC.0000000000000921.
    PubMed     Text format     Abstract available


  70. KIM M, Suh DH, Kim K, Lee HJ, et al
    Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gynecol Cancer. 2017;27:332-338.
    PubMed     Text format     Abstract available


  71. GUO X, Dong Z, Yamada S, Li Y, et al
    Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:206-213.
    PubMed     Text format     Abstract available


  72. HARTMAN CA, Teixeira JC, Barbosa SB, Figueiredo SM, et al
    Analysis of Conservative Surgical Treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Int J Gynecol Cancer. 2017;27:357-363.
    PubMed     Text format     Abstract available


    January 2017
  73. YANG K, Park W, Huh SJ, Park BK, et al
    Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000909.
    PubMed     Text format     Abstract available


  74. BOGANI G, Ditto A, Martinelli F, Signorelli M, et al
    Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery.
    Int J Gynecol Cancer. 2017 Jan 26. doi: 10.1097/IGC.0000000000000902.
    PubMed     Text format     Abstract available


  75. NEGRAO MV, Lima JM, Silva SC, Diz MD, et al
    Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?
    Int J Gynecol Cancer. 2017 Jan 19. doi: 10.1097/IGC.0000000000000914.
    PubMed     Text format     Abstract available


  76. SLAMA J, Fischerova D, Zikan M, Kocian R, et al
    Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers.
    Int J Gynecol Cancer. 2017;27:147-153.
    PubMed     Text format     Abstract available


    December 2016
  77. SASAKI Y, Iwanari O, Arakawa I, Moriya T, et al
    Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
    Int J Gynecol Cancer. 2016 Dec 16. doi: 10.1097/IGC.0000000000000898.
    PubMed     Text format     Abstract available


  78. CHEN X, Zou H, Li H, Lin R, et al
    Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  79. DERKS M, van Lonkhuijzen LR, Bakker RM, Stiggelbout AM, et al
    Long-Term Morbidity and Quality of Life in Cervical Cancer Survivors: A Multicenter Comparison Between Surgery and Radiotherapy as Primary Treatment.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  80. GRAVES S, Seagle BL, Strohl AE, Shahabi S, et al
    Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  81. KIM YJ, Kim BR, Ryu JS, Lee GO, et al
    HNRNPA1, a Splicing Regulator, Is an Effective Target Protein for Cervical Cancer Detection: Comparison With Conventional Tumor Markers.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  82. EMMETT M, Gildea C, Nordin A, Hirschowitz L, et al
    Variations in Treatment of Cervical Cancer According to Tumor Morphology-Population-Based Cohort Analysis of English National Cancer Registration Data.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    November 2016
  83. HANPRASERTPONG J, Jiamset I, Geater A, Peerawong T, et al
    The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  84. SUN P, Shen Y, Gong JM, Zhou LL, et al
    A New MicroRNA Expression Signature for Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    October 2016
  85. DIAB Y
    Sentinel Lymph Nodes Mapping in Cervical Cancer a Comprehensive Review.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    September 2016
  86. NAKAMURA K, Masuyama H, Ida N, Haruma T, et al
    Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  87. LEE KC, Kim HJ, Sung K, Choi YE, et al
    The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  88. ZUSTERZEEL PL, Pol FJ, van Ham M, Zweemer RP, et al
    Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.
    Int J Gynecol Cancer. 2016;26:1293-9.
    PubMed     Text format     Abstract available


  89. RYCHLIK A, Marin S, De Santiago J, Zapardiel I, et al
    Utility of Laparoscopic Indocyanine Green-Guided Sentinel Node Biopsy in Open Cervical Cancer Surgery.
    Int J Gynecol Cancer. 2016;26:1288-9.
    PubMed     Text format     Abstract available


  90. MABUCHI S, Yokoi E, Owa T, Kozasa K, et al
    Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy.
    Int J Gynecol Cancer. 2016;26:1281-7.
    PubMed     Text format     Abstract available


  91. WANG W, Chu HJ, Shang CL, Gong X, et al
    Long-Term Oncological Outcomes After Laparoscopic Versus Abdominal Radical Hysterectomy in Stage IA2 to IIA2 Cervical Cancer: A Matched Cohort Study.
    Int J Gynecol Cancer. 2016;26:1264-73.
    PubMed     Text format     Abstract available


    August 2016
  92. RICCI C, Scambia G, De Vincenzo R
    Locally Advanced Cervical Cancer in Pregnancy: Overcoming the Challenge. A Case Series and Review of the Literature.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    July 2016
  93. KHATIB G, Kucukgoz Gulec U, Baris Guzel A, Uygur B, et al
    A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  94. DERKS M, van der Velden J, Frijstein MM, Vermeer WM, et al
    Long-term Pelvic Floor Function and Quality of Life After Radical Surgery for Cervical Cancer: A Multicenter Comparison Between Different Techniques for Radical Hysterectomy With Pelvic Lymphadenectomy.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  95. KIM DH, Kim WT, Bae JS, Ki YK, et al
    Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiothe
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  96. NOGUEIRA-RODRIGUES A, Melo AC, Garces AH, Paulino E, et al
    Patterns of Care and Outcome of Elderly Women Diagnosed With Cervical Cancer in the Developing World.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  97. ZHANG S, Wang S, Lv A, Huang S, et al
    Laparoscopically Assisted Radical Vaginal Hysterectomy for Early-Stage Cervical Cancer: A Systemic Review and Meta-Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  98. MARTINEZ-FERNANDEZ MI, Legaspi Folgueira J, Valtuena Peydro G, Cambeiro M, et al
    Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2016;26:1162-8.
    PubMed     Text format     Abstract available


    June 2016
  99. YOON A, Park JJ, Park BK, Lee YY, et al
    Long-term Outcomes of MRI Stage IIB Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  100. UJIHIRA T, Ota T, Kusunoki S, Sugimori Y, et al
    Outcome of Neoadjuvant Intra-Arterial Chemotherapy and Radical Hysterectomy for Treatment of Bulky Stage IB to Stage IIB Uterine Cervical Cancer: Can Postoperative Irradiation Be Avoided?
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  101. GUBBALA PK, Laios A, Wang Z, Dhar S, et al
    Routine Intraoperative Frozen Section Examination to Minimize Bimodal Treatment in Early-Stage Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  102. YU X, Zhao W, Yang X, Wang Z, et al
    miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R.
    Int J Gynecol Cancer. 2016;26:851-8.
    PubMed     Text format     Abstract available


  103. ZHOU Q, Han LR, Zhou YX, Li Y, et al
    MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3.
    Int J Gynecol Cancer. 2016;26:817-24.
    PubMed     Text format     Abstract available


    May 2016
  104. ONAL C, Guler OC, Yildirim BA
    Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  105. YANG F, Young L, Grigsby P
    Predictive Value of Standardized Intratumoral Metabolic Heterogeneity in Locally Advanced Cervical Cancer Treated With Chemoradiation.
    Int J Gynecol Cancer. 2016;26:777-784.
    PubMed     Text format     Abstract available


    April 2016
  106. EIBYE S, Kruger Kjaer S, Nielsen TS, Mellemkjaer L, et al
    Mortality Among Women With Cervical Cancer During or Shortly After a Pregnancy in Denmark 1968 to 2006.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  107. ZHANG L, Zhan X, Yan D, Wang Z, et al
    Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  108. PHIPPEN NT, Havrilesky LJ, Barnett JC, Hamilton CA, et al
    Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  109. DUTTA S, Singh RK, Mandal RK, Roychoudhury S, et al
    Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


    March 2016
  110. BAE HS, Kim YJ, Lim MC, Seo SS, et al
    Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  111. ABDALLAH R, Bush SH, Chon HS, Apte SM, et al
    Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Int J Gynecol Cancer. 2016;26:553-60.
    PubMed     Text format     Abstract available


  112. SATO S, Shimada M, Ohta T, Kojimahara T, et al
    Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:561-7.
    PubMed     Text format     Abstract available


  113. HAO M, Wang Z, Wei F, Wang J, et al
    Cavitron Ultrasonic Surgical Aspirator in Laparoscopic Nerve-Sparing Radical Hysterectomy: A Pilot Study.
    Int J Gynecol Cancer. 2016;26:594-9.
    PubMed     Text format     Abstract available


  114. ALCAZAR JL, Arribas S, Martinez-Monge R, Jurado M, et al
    Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Int J Gynecol Cancer. 2016;26:534-8.
    PubMed     Text format     Abstract available


    February 2016
  115. XIE X, Song K, Cui B, Jiang J, et al
    Significance of the Factors Associated With Parametrial Involvement in Stage IB to IIA Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  116. GONG L, Zhang JW, Yin RT, Wang P, et al
    Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  117. KIM MK, Sim JA, Yun YH, Bae DS, et al
    Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  118. KOTSOPOULOS IC, Kucukmetin A, Mukhopadhyay A, Lunec J, et al
    Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  119. CHANG Y, Yang ZY, Li GL, Li Q, et al
    Correlations Between Radiation Dose in Bone Marrow and Hematological Toxicity in Patients With Cervical Cancer: A Comparison of 3DCRT, IMRT, and RapidARC.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  120. DHULL VS, Khangembam BC, Sharma P, Rana N, et al
    Surgical Scar Site Recurrence in Patients With Cervical Cancer on 18F-FDG PET-CT: A Case-Control Study.
    Int J Gynecol Cancer. 2016;26:354-60.
    PubMed     Text format     Abstract available


  121. ZHOU G, Chen X, Tang F, Zhou J, et al
    The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy.
    Int J Gynecol Cancer. 2016;26:361-6.
    PubMed     Text format     Abstract available


  122. VRANES B, Milenkovic S, Radojevic M, Soldatovic I, et al
    Risk of Parametrial Spread in Small Stage I Cervical Carcinoma: Pathology Review of 223 Cases With a Tumor Diameter of 20 mm or Less.
    Int J Gynecol Cancer. 2016;26:416-21.
    PubMed     Text format     Abstract available


    January 2016
  123. ZANAGNOLO V, Minig L, Rollo D, Tomaselli T, et al
    Clinical and Oncologic Outcomes of Robotic Versus Abdominal Radical Hysterectomy for Women With Cervical Cancer: Experience at a Referral Cancer Center.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  124. CORRADO G, Cutillo G, Saltari M, Mancini E, et al
    Surgical and Oncological Outcome of Robotic Surgery Compared With Laparoscopic and Abdominal Surgery in the Management of Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  125. SIESTO G, Romano F, Accardi A, Bulletti C, et al
    Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  126. SASANO T, Mabuchi S, Kuroda H, Takahashi R, et al
    Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  127. LATERZA RM, Uccella S, Casarin J, Morosi C, et al
    Recurrence of Early Stage Cervical Cancer After Laparoscopic Versus Open Radical Surgery.
    Int J Gynecol Cancer. 2016.
    PubMed     Text format     Abstract available


  128. LINDSAY R, Burton K, Shanbhag S, Millan D, et al
    Reply to the "Letter to the Editor re: Fertility Conserving Management of Early Cervical Cancer: Our Experience of LLETZ and Pelvic Lymph Node Dissection" by Dr. MK Mehasseb (Int J Gynecol Cancer. 2015;25:2-3).
    Int J Gynecol Cancer. 2016;26:34.
    PubMed     Text format    


  129. LEBLANC E, Katdare N, Narducci F, Bresson L, et al
    Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
    Int J Gynecol Cancer. 2016;26:169-75.
    PubMed     Text format     Abstract available


  130. SHI R, Wei W, Jiang P
    Laparoscopic Nerve-Sparing Radical Hysterectomy for Cervical Carcinoma: Emphasis on Nerve Content in Removed Cardinal Ligaments.
    Int J Gynecol Cancer. 2016;26:192-8.
    PubMed     Text format     Abstract available


  131. KI EY, Lee KH, Hur SY, Rhee JE, et al
    Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
    Int J Gynecol Cancer. 2016;26:176-83.
    PubMed     Text format     Abstract available


  132. CHANG WC, Li CH, Chu LH, Huang PS, et al
    Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
    Int J Gynecol Cancer. 2016;26:156-62.
    PubMed     Text format     Abstract available


    November 2015
  133. SAGAE S, Monk BJ, Pujade-Lauraine E, Gaffney DK, et al
    Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    October 2015
  134. KASUGA Y, Nishio H, Miyakoshi K, Sato S, et al
    Pregnancy Outcomes After Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer: A 13-Year Experience in a Single Tertiary-Care Center.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  135. KONG TW, Piao X, Chang SJ, Paek J, et al
    A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  136. SALA E, Micco M, Burger IA, Yakar D, et al
    Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2015;25:1461-7.
    PubMed     Text format     Abstract available


    September 2015
  137. KAWANO M, Mabuchi S, Matsumoto Y, Sasano T, et al
    Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive Radiotherapy.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  138. ZHOU X, Xu CJ, Wang JX, Dai T, et al
    Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    August 2015
  139. HSIEH GL, Linesch S, Sajjad A, Macdonald A, et al
    Treatment Compliance and Outcomes for Women With Locoregionally Advanced Cervical Cancer Treated in a Safety Net Health System.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  140. CHEN X, Zhu B, Luo Y, Zhang D, et al
    Interleukin-28B Plays a Therapeutic Role on Mouse U14 Cervical Cancer Cells by Down-Regulating CD4+CD25+FoxP3+Regulatory T Cells In Vivo.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  141. MU X, Zhao J, Yuan X, Zhao X, et al
    Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  142. BRADBURY M, Founta C, Taylor W, Kucukmetin A, et al
    Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    July 2015
  143. BUDA A, Lissoni AA, Floriani I, Biagioli E, et al
    Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


    June 2015
  144. NISHIDA T, Nakamura K, Haraga J, Ogawa C, et al
    The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  145. SIMONDS HM, Neugut AI, Jacobson JS
    HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation.
    Int J Gynecol Cancer. 2015;25:884-90.
    PubMed     Text format     Abstract available


    May 2015
  146. JIANG E, Sun X, Kang H, Sun L, et al
    Dehydrocostus Lactone Inhibits Proliferation, Antiapoptosis, and Invasion of Cervical Cancer Cells Through PI3K/Akt Signaling Pathway.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  147. LIU Y, Ye Z, Sun H, Bai R, et al
    Clinical Application of Diffusion-Weighted Magnetic Resonance Imaging in Uterine Cervical Cancer.
    Int J Gynecol Cancer. 2015.
    PubMed     Text format     Abstract available


  148. SCHNEIDER A, Kohler C
    Locoregional recurrence after laparoscopic radical trachelectomy: the vaginal cuff must be closed to avoid tumor cell contamination of the peritoneal cavity.
    Int J Gynecol Cancer. 2015;25:550.
    PubMed     Text format    


    March 2015
  149. ALTOBELLI E, Lattanzi A
    Cervical carcinoma in the European Union: an update on disease burden, screening program state of activation, and coverage as of March 2014.
    Int J Gynecol Cancer. 2015;25:474-83.
    PubMed     Text format     Abstract available


  150. SONG E, Yu W, Xiong X, Kuang X, et al
    Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling.
    Int J Gynecol Cancer. 2015;25:345-55.
    PubMed     Text format     Abstract available


    February 2015
  151. FRANKE O, Narducci F, Chereau-Ewald E, Orsoni M, et al
    Role of a double docking to improve lymph node dissection: when robotically assisted laparoscopy for para-aortic lymphadenectomy is associated to a pelvic procedure.
    Int J Gynecol Cancer. 2015;25:331-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: